Your participation can lead to important medical advances

Thank you to all of our patients who have helped advance treatment for all!

By participating in clinical trials, you are an important part of the celebration of new treatments approved by the Food and Drug Administration (FDA)! Here are some recently approved medications that patients at Oregon Medical Research Center helped make available.


  • Skyrizi (risankizumab)
  • Ilumya (tildrakizumab-asmn)
  • Cimzia (certolizumab pegol)
  • Tremfya (guselkumab)
  • Siliq (brodalumab)
  • Taltz (ixekizumab)
  • Cosentyx (secukinumab)
  • Otezla (apremilast)
  • Stelara (ustekinumab)
  • Humira (adalimumab)
  • Remicade (infliximab)
  • Enbrel (etanercept)
  • Sorilux (calcipotriene) foam
  • Xeljanz (tofacitinib citrate)

Atopic Dermatitis – Eczema

  • Dupixent (dipilumab)
  • Eucrisa (crisaborole)

Onychomycosis – Toenail Fungus

  • Jublia (efinaconazole)
  • Ciclopirox topical (generic)

Actinic Keratosis

  • Picato (ingenol mebutate)
  • Efudex (5-fluorouracil)
  • Zyclara (imiquimod) and generic imiquimod
  • Levulan Kerastick (aminolevulinic acid HCI)


  • Rhofade (oxymetazoline)
  • Mirvaso (brimonidine)
  • Oracea (doxycycline)

Other Approvals

  • Qbrexza (glycopyrronium) for hyperhidrosis (excessive sweating)
  • Eskata (hydrogen peroxide) for raised seborrheic keratoses (SKs)
  • Botox (onabotulinumtoxinA) for severe sweating, frown lines, crow’s feet
  • Latisse (bimatoprost ophthalmic solution) for thinning eyelashes
  • Emervel Deep for facial wrinkles
  • Naftifine (generic) for skin infections